EQT Posts $20bn Galderma Gain, AUM Flat

EQT's sale of Galderma generated about $20 billion capital gain, the largest fully monetized gain for a single PE fund.
Fee‑generating assets under management held steady at €142 billion in Q1, while total AUM slipped to €269 billion from €273 billion.
Gross fund investments rose to €6 billion, co‑investment opportunities hit €4 billion, and share repurchases totaled €34 million in the quarter.
EQT agreed to acquire Coller Capital, aiming to double its €30 billion fee‑generating AUM within four years, closing Q3 2026.